Legacy Bridge, LLC Abbott Laboratories Transaction History

Legacy Bridge, LLC

$178 Million
Q3 2024

A detailed history of Legacy Bridge, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Legacy Bridge, LLC holds 2,951 shares of ABT stock, worth $347,509. This represents 0.19% of its overall portfolio holdings.

Number of Shares

2,951

Previous 2,951 -0.0%

Holding current value

$347,509

Previous $306,000 9.8%

% of portfolio

0.19%

Previous 0.19%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$90.19 - $110.4 $36,526 - $44,712	-405 Reduced 12.07%	2,951 $324,000
Q3 2023 Oct 11, 2023	SELL	$95.53 - $114.62 $38,212 - $45,848	-400 Reduced 10.65%	3,356 $325,000
Q2 2023 Jul 11, 2023	BUY	$100.78 - $112.29 $20,156 - $22,458	200 Added 5.62%	3,756 $409,000
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $8,165 - $9,869	-80 Reduced 2.2%	3,556 $386,000
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $27,934 - $34,064	-245 Reduced 6.31%	3,636 $430,000
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $17,329 - $21,219	-150 Reduced 3.72%	3,881 $546,000
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $52,680 - $67,424	-688 Reduced 14.58%	4,031 $369,000
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $28,897 - $42,255	-460 Reduced 8.88%	4,719 $372,000
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $54,014 - $60,131	688 Added 15.32%	5,179 $450,000
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $56,305 - $61,053	-688 Reduced 13.28%	4,491 $376,000
Q4 2018 Jan 25, 2019	BUY	$65.56 - $74.27 $339,535 - $384,644	5,179 New	5,179 $375,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Bridge, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Bridge, LLC with notifications on news.

Account

Legacy Bridge, LLC Abbott Laboratories Transaction History